Article
Identification of novel mutations associated with cycloserine resistance in Mycobacterium tuberculosis.
The Journal of antimicrobial chemotherapy - 1 Dec 2017
Chen Jiazhen, Zhang Shuo, Cui Peng, Shi Wanliang, Zhang Wenhong, Zhang Ying
Abstract excerpt
OBJECTIVES: d-Cycloserine is an important second-line drug used to treat MDR- and XDR-TB. However, the mechanisms of resistance to d-cycloserine are not well understood. Here we investigated the molecular basis of d-cycloserine resistance using in vitro-isolated resistant mutants. METHODS: Mycobacterium tuberculosis H37Rv was subjected to mutant selection on 7H11 agar plates containing varying concentrations of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
